El Salvador is to create the Superintendency for Health Regulation (SHR), a new regulatory body that will authorize medicines and medical devices, grant export and import licenses and set medicine prices. The move is expected to strengthen the national health system and protect patients, as well as make El Salvador a more competitive pharmaceutical market.
El Salvador Sets Up New Regulatory Body To Oversee Medicines & Devices
El Salvador has approved a law that will establish a new regulatory body responsible for authorizing medicines and setting prices.
More from Latin America
• By
CMED, which sets medicine prices in Brazil, has published the maximum price adjustment index for 2025.
• By
The Brazilian medicines regulator will also offer more clarity on the requirements for radiopharmaceuticals that are exempt from registration.
• By
Brazil’s drug regulator ANVISA has also published its first post-marketing authorization monitoring reports on advanced therapies Yescarta, Zolgenma, Kymriah, Carvykti and Luxturna.
• By
Health technology assessment bodies in England, the US, Canada, Australia, the Netherlands and Colombia have joined forces to produce guidance for drug developers on using surrogate endpoints for cost-effectiveness analyses.
More from Geography
• By
Coverage data from the two programs suggest Medicare beneficiaries may be more disappointed than Medicaid enrollees by the Trump Administration’s decision not to mandate the programs cover obesity drugs.
• By
The new telework policy returns to the pre-COVID-19 pandemic standard, but still requires reviewers to be at White Oak for sponsor meetings and divisions to have an in-office presence every day.
• By
The HHS Secretary publicly acknowledged the unusual delay of Novavax's COVID-19 vaccine licensure, but his justification was neither scientifically accurate nor legally justifiable, experts said.